EPX-HTG for Structural Heart Procedures
NCT: NCT07705425 · NOT_YET_RECRUITING
Brief Summary
To investigate and evaluate the benefits of adding EchoPixel Holographic Therapy Guidance to the current standard of care in Structural Heart (SH) procedures. Current structural heart (SH) procedures rely on standard image guidance (SIG) relies on 2D X-plane or multiplanar reformatted (MPR) views that can conceal critical anatomy elements at the time of implant or therapy delivery which are crucial to achieve an optimal long term durable outcome. This limitation complicates an operator's task of optimally implanting a 3D device, delivered by tools that rotate and maneuver in 3D, within a dynamic 3D anatomy, the heart. Slight mismatches between the device and the target in the heart are indicative of a sub-optimal device position, a key risk-factor of peri-device leak (PDL) and other complications. The primary objective of the study is to determine if including EchoPixel - HTG as an additive visualization procedural tool has a positive impact on optimal procedure outcomes for patients undergoing in Structural Heart (SH) procedures.
Frequently Asked Questions
What is EPX-HTG for Structural Heart Procedures?
EPX-HTG for Structural Heart Procedures is a clinical trial registered under NCT07705425. Current status: NOT_YET_RECRUITING.
What is the status of NCT07705425?
The current status of NCT07705425 (EPX-HTG for Structural Heart Procedures) is: NOT_YET_RECRUITING.
When did EPX-HTG for Structural Heart Procedures start?
EPX-HTG for Structural Heart Procedures started on 2026-08-03.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.